☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
PharmaShots Interview: Ikena Oncology’ Mark Manfredi Shares Insight on IK-930 for the Treatment of Solid Tumors
April 5, 2022
Imara to Discontinue P-IIb (Ardent & Forte) Trial of Tovinontrine (IMR-687) for the Treatment of Sickle Cell Disease and Beta-Thal...
April 5, 2022
BMS’ Opdivo (nivolumab) Receives the EC’s Approval as Adjuvant Treatment for Patients with High-Risk Muscle-Invasive Urothelial Ca...
April 5, 2022
Protalix BioTherapeutics and Chiesi Report Results of PRX-102 in P-III (BALANCE) Trial for the Treatment of Fabry Disease
April 5, 2022
Argenx Presents Interim Results of Vyvgart (efgartigimod alfa-fcab) in P-III (ADAPT+) Trial for Generalized Myasthenia Gravis at A...
April 5, 2022
Immunocore’s Kimmtrak (tebentafusp) Receives the EC’s Approval for the Treatment of Unresectable or Metastatic Uveal Melanoma
April 5, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions